EMBO announces 64 newly elected members

8 June 2021 – EMBO is pleased to announce that 64 life scientists have been elected to its membership. The new EMBO Members and Associate Members join the community of more than 1,800 leading life scientists.

“I am delighted to welcome the new members into our organization and look forward to working with them,” says EMBO Director Maria Leptin. “An election to the EMBO Membership recognizes outstanding achievements in the life sciences. The new members will provide expertise and guidance that will help EMBO to further strengthen its initiatives.”

The 64 newly elected members reside in 21 countries: 55 new EMBO Members reside in member states of the EMBC, the intergovernmental organization that funds the major EMBO Programmes and activities. Nine new EMBO Associate Members reside in Argentina, Australia, India, Japan, and the USA. 26 of the new EMBO Members (41%) are women.

EMBO Members are actively involved in the organization. They serve on EMBO Council, Committees and Advisory Editorial Boards of EMBO Press journals, evaluate applications for EMBO funding, and mentor early-career scientists. Collectively, they can influence the direction of the life sciences in Europe and beyond.

New members are nominated and elected by the existing EMBO Membership; it is not possible to apply to become a member. One election is held each year. The new EMBO Members will be formally welcomed at the annual EMBO Members’ Meeting between 27 and 29 October 2021.

A directory of all EMBO Members, their affiliations and subject areas is available online:

https:/

/

people.

embo.

org/


Selected statistics

  • 64 life scientists have been elected to the EMBO Membership, 55 EMBO Members and nine Associate Members.
  • The newly elected members reside in 21 countries.
  • 26 of the new EMBO Members (41 %) are women.


New EMBO Members 2021

Nathalie Q. Balaban Hebrew University, Jerusalem, IL

Alex Bateman European Bioinformatics Institute (EMBL-EBI), Hinxton, UK

Martin Beck Max Planck Institute of Biophysics, Frankfurt am Main, DE

Laurent Blanchoin Interdisciplinary Research Institute of Grenoble, FR

Adrian P. Bracken Trinity College, Dublin, IE

Inês Cardoso Pereira Instituto de Tecnologia Química e Biológica António Xavier, Oeiras, PT

Petr Cejka Institute for Research in Biomedicine, Bellinzona, CH

Jacqueline Cherfils École Normale Supérieure, Paris, FR

Rosa Cossart Aix Marseille University, Inserm, INMED, Marseille, FR

Peter J. Cullen University of Bristol, UK

Karin E. de Visser Netherlands Cancer Institute, Amsterdam, and Oncode Institute, Utrecht, NL

Miguel A. Del Pozo Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, ES

José Antonio Enríquez Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, ES

Tobias J. Erb Max Planck Institute for Terrestrial Microbiology, Marburg, DE

Ji?í Fajkus Masaryk University, Brno, CZ

Rebecca C. Fitzgerald MRC Cancer Cell Unit, University of Cambridge, UK

Ervin Fodor Sir William Dunn School, Oxford, UK

Toni Gabaldón Barcelona Supercomputing Centre (BSC-CNS) and Institute for Research in Biomedicine (IRB), Barcelona, ES

Julie E. Gray University of Sheffield, UK

Takashi Hiiragi EMBL, Heidelberg, DE

Corinne Houart King’s College and Francis Crick Institute, London, UK

Evelyn Houliston Villefranche-sur-Mer Developmental Biology Laboratory, FR

Matthew E. Hurles Wellcome Sanger Institute, Cambridge, UK

Matteo Iannacone San Raffaele Scientific Institute and University, Milano, IT

Kim B. Jensen BRIC, University of Copenhagen, DK

Robert J. Klose University of Oxford, UK

Alwin Köhler Max Perutz Labs, Vienna, AT

Cris Kuhlemeier University of Bern, CH

Gianni Liti IRCAN, Université Côte d’Azur, Nice, FR

Robbie Loewith University of Geneva, CH

Ilaria Malanchi Francis Crick Institute, London, UK

John C. Marioni EMBL-EBI and University of Cambridge, UK

Elisa Martí Instituto de Biología Molecular de Barcelona (IBMB), ES

Massimiliano Mazzone VIB – KU Leuven Center for Cancer Biology, BE

F. Nina Papavasiliou Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, DE

Balázs Papp Biological Research Centre and HCEMM, Szeged, HU

Diego Pasini European Institute of Oncology IRCCS and University of Milan, IT

Andrea Pauli IMP, Vienna, AT

Rosa Rademakers VIB-UA Center for Molecular Neurology, University of Antwerp, BE

Markus Ralser Charité – Universitätsmedizin, Berlin, DE and Francis Crick Institute, London, UK

Juri Rappsilber Technische Universität, Berlin, DE

Oded Rechavi Tel Aviv University, IL

Beatriz Rico Centre for Developmental Neurobiology, King’s College London, UK

U?ur ?ahin Johannes-Gutenberg-Universität, Mainz, DE

Liliane Schoofs KU Leuven, BE

Zofia Szweykowska-Kuli?ska Adam Mickiewicz University, Poznan, PL

Kristin Tessmar-Raible Max Perutz Labs, University of Vienna, AT

Özlem Türeci BioNTech SE, Mainz, DE

Wim Vermeulen Erasmus University MC, Rotterdam, NL

Raphael Voituriez CNRS / Sorbonne Université, Paris, FR

Eilika Weber-Ban ETH Zurich, CH

Karsten Weis ETH Zurich, CH

Karina B. Xavier Instituto Gulbenkian de Ciência, Oeiras, PT

Eleftheria Zeggini Helmholtz Zentrum München, Neuherberg, DE

Denise Zickler Institute for Integrative Biology of the Cell (I2BC), University of Paris-Saclay, Orsay, FR

New EMBO Associate Members 2021

Yasmine Belkaid NIAID, NIH, Bethesda, US

Hugo J. Bellen Baylor College of Medicine, Houston, US

María Fernanda Ceriani Fundación Instituto Leloir, IIB-BA/CONICET, Buenos Aires, AR

Mark Dawson Peter MacCallum Cancer Centre, Melbourne, AU

Akiko Iwasaki Yale University School of Medicine/HHMI, New Haven, US

Roop Mallik Indian Institute of Technology, Mumbai, IN

Keiko Sugimoto RIKEN Center for Sustainable Resource Science, Yokohama, JP

Masayo Takahashi Kobe City Eye Hospital, Kobe, JP

Leonard Zon Boston Children’s Hospital, US

###


About EMBO

EMBO is an organization of more than 1,800 leading researchers that promotes excellence in the life sciences in Europe and beyond. The major goals of the organization are to support talented researchers at all stages of their careers, stimulate the exchange of scientific information, and help build a research environment where scientists can achieve their best work.

EMBO helps young scientists to advance their research, promote their international reputations and ensure their mobility. Courses, workshops, conferences and scientific journals disseminate the latest research and offer training in techniques to maintain high standards of excellence in research practice. EMBO helps to shape science and research policy by seeking input and feedback from our community and by following closely the trends in science in Europe. For more information:

http://www.

embo.

org

This part of information is sourced from https://www.eurekalert.org/pub_releases/2021-06/e-ea6060821.php